Severe Combined Immunodeficiency Due to DCLRE1C Deficiency
Immunology·MeSH: Glucosephosphate Dehydrogenase Deficiency
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Severe Combined Immunodeficiency Due to DCLRE1C Deficiency?
There are 1 clinical trial targeting Severe Combined Immunodeficiency Due to DCLRE1C Deficiency tracked by BioSniper.
What is the prevalence of Severe Combined Immunodeficiency Due to DCLRE1C Deficiency?
The estimated prevalence of Severe Combined Immunodeficiency Due to DCLRE1C Deficiency is approximately 5.0 per 100,000 population.
Deep-dive into Severe Combined Immunodeficiency Due to DCLRE1C Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis